Results 71 to 80 of about 142 (121)
Exploring the Depths of Cryptic Aspergillosis: Species Variability, Clinical Spectrum, Diagnostic Quandaries and Therapeutic Options [PDF]
Cryptic aspergillosis, characterised by infections caused by non classical Aspergillus species, presents unique challenges in clinical management due to species variability, diverse clinical manifestations, diagnostic complexities, and limited treatment ...
Almas Fathima Upaisal +1 more
doaj +1 more source
Abstract Background and Aims Inconsequential diseases can sometimes become extremely dangerous through mutation. Antifungal resistance has increased by 24%, and resistance only due to Candida auris (C. auris) species have increased by 60%. Here, we aimed to assess the knowledge of antifungal treatment and preventative measures to mitigate the ...
Md. Ashrafur Rahman +4 more
wiley +1 more source
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida
ABSTRACTBackgroundInvasive candidiasis (IC) is increasing due to the rising numbers of immunocompromised patients. Increasing azole resistance rates and daily dosing required for most echinocandins have complicated its treatment. The approval of rezafungin has provided an option for weekly echinocandin treatment.
Marisa L. Winkler +4 more
openaire +2 more sources
Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review
Intra-abdominal candidiasis (IAC), with or without candidemia, is a common condition in patients in intensive care units (ICUs). Early diagnosis of IAC remains a challenge for clinicians despite new biomarkers. Early and appropriate antifungal treatment,
Marco Marotta Pais +4 more
doaj +1 more source
Fungal endocarditis: microbial insights, diagnostic and therapeutic challenges in the modern era [PDF]
Fungal endocarditis (FE) is still an uncommon but devastating infection, especially when immunosuppression, prosthetic valve surgery, or prolonged health care is involved.
Sudeep Edpuganti
doaj +1 more source
Invasive Pilzinfektionen wie Candidämie und invasive Candidiasis erfordern häufig langwierige stationäre Behandlungen aufgrund des kontinuierlichen Therapiebedarfs und gehen mit hohen Sterblichkeitsraten einher.
Prof. Dr. rer. medic. Florian Kron +6 more
doaj +1 more source
Candida glabrata (also known as Nakaseomyces glabratus) is the second most common cause of candidiasis, next to Candida albicans, and is rising in prevalence due to intrinsic and acquired mechanisms of antifungal resistance.
Timothy J. Nickels, Kyle W. Cunningham
doaj +1 more source
The Silent Pandemic: Antifungal Resistance and the Future of Invasive Fungal Disease Management
Invasive fungal diseases (IFDs) represent an escalating global health threat, compounded by the rapid emergence of antifungal resistance (AFR). This review synthesizes the contemporary landscape of AFR from clinical and microbiological perspectives ...
Ruchika Bagga +1 more
doaj +1 more source
Periodic surveillance of antifungal susceptibility among Aspergillus isolates is essential to guide effective treatment. This multicenter study analyzed 550 clinical Aspergillus isolates collected in Taiwan from 2021 to 2023, primarily from the ...
Ming-I Hsieh +4 more
doaj +1 more source
Antifungal Agents in the 21st Century: Advances, Challenges, and Future Perspectives
Invasive fungal infections (IFIs) represent a growing global health threat, particularly for immunocompromised populations, with mortality exceeding 1.5 million deaths annually.
Francesco Branda +7 more
doaj +1 more source

